FR2247257A1 - - Google Patents

Info

Publication number
FR2247257A1
FR2247257A1 FR7434341A FR7434341A FR2247257A1 FR 2247257 A1 FR2247257 A1 FR 2247257A1 FR 7434341 A FR7434341 A FR 7434341A FR 7434341 A FR7434341 A FR 7434341A FR 2247257 A1 FR2247257 A1 FR 2247257A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7434341A
Other versions
FR2247257B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2247257A1 publication Critical patent/FR2247257A1/fr
Application granted granted Critical
Publication of FR2247257B1 publication Critical patent/FR2247257B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7434341A 1973-10-12 1974-10-11 Expired FR2247257B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/406,013 US3966949A (en) 1973-10-12 1973-10-12 Pharmaceutical compositions and preparing same

Publications (2)

Publication Number Publication Date
FR2247257A1 true FR2247257A1 (fr) 1975-05-09
FR2247257B1 FR2247257B1 (fr) 1977-11-04

Family

ID=23606175

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7434341A Expired FR2247257B1 (fr) 1973-10-12 1974-10-11

Country Status (9)

Country Link
US (1) US3966949A (fr)
BE (1) BE820775A (fr)
CA (1) CA1043260A (fr)
DE (1) DE2448119C2 (fr)
FR (1) FR2247257B1 (fr)
GB (1) GB1437880A (fr)
NL (1) NL184197C (fr)
PH (1) PH10451A (fr)
ZA (1) ZA745756B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380023A1 (fr) * 1989-01-23 1990-08-01 Merrell Dow Pharmaceuticals Inc. Compositions pharmaceutiques liquides contenant un antihistaminique du type alcool pipéridinylalkylique
WO1992001441A1 (fr) * 1990-07-21 1992-02-06 Knoll Aktiengesellschaft Formulation stable de substance active

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0812195T3 (da) * 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
JP4344405B2 (ja) * 1997-08-26 2009-10-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
EP1465600B1 (fr) * 2001-12-20 2007-03-07 Alpex Pharma SA Compositions particulaires comprenant un liquide lipophile
KR20060082037A (ko) * 2003-07-02 2006-07-14 아스트라제네카 아베 퀘티아핀의 대사산물
JPWO2005089716A1 (ja) * 2004-03-24 2008-01-31 武田薬品工業株式会社 高含量化製剤
WO2007062339A2 (fr) * 2005-11-18 2007-05-31 Astrazeneca Ab Formulations liquides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
DE1795362A1 (de) * 1968-09-19 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US3652658A (en) * 1969-01-23 1972-03-28 Josef Fried Ester derivatives of bis(p-(amino-lower alkyleneoxy)phenyl)alkanols
US3683084A (en) * 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380023A1 (fr) * 1989-01-23 1990-08-01 Merrell Dow Pharmaceuticals Inc. Compositions pharmaceutiques liquides contenant un antihistaminique du type alcool pipéridinylalkylique
WO1992001441A1 (fr) * 1990-07-21 1992-02-06 Knoll Aktiengesellschaft Formulation stable de substance active

Also Published As

Publication number Publication date
NL7412644A (nl) 1975-04-15
AU7314974A (en) 1976-03-18
ZA745756B (en) 1975-10-29
DE2448119A1 (de) 1975-04-17
BE820775A (fr) 1975-02-03
DE2448119C2 (de) 1984-03-29
GB1437880A (en) 1976-06-03
CA1043260A (fr) 1978-11-28
PH10451A (en) 1977-03-31
NL184197B (nl) 1988-12-16
FR2247257B1 (fr) 1977-11-04
US3966949A (en) 1976-06-29
NL184197C (nl) 1989-05-16

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AR199451A1 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU477823B2 (fr)
AU461342B2 (fr)
AU471461B2 (fr)
AR200256A1 (fr)
AU476873B1 (fr)
AR210729A1 (fr)
AU477824B2 (fr)

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name